Outlook Therapeutics Incs. (OTLK) PT Raised to $8 at Brookline Capital Markets, Following Clinical Business Update

August 3, 2021 11:28 AM EDT Send to a Friend
Brookline Capital Markets analyst Kumaraguru Raja raised the price target on Outlook Therapeutics Incs. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login